September 11, 2017 / 5:24 PM / a month ago

BRIEF-Erytech Pharma H1 net loss widens to ‍​14.0 million euros

Sept 11 (Reuters) - ERYTECH PHARMA SA:

* ERYTECH REPORTS FIRST HALF 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* ‍SOLID CASH POSITION OF EUR 88.5 MILLION AS OF JUNE 30, 2017​

* H1 OPERATING LOSS EUR ‍​14.2 MILLION VERSUS LOSS OF EUR 10.6 MILLION YEAR AGO

* H1 NET LOSS EUR ‍​14.0 MILLION VERSUS LOSS OF EUR 10.3 MILLION YEAR AGO

* H1 TOTAL OPERATING INCOME EUR ‍​ 1.8 MILLION VERSUS EUR 2.4 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below